These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9765315)
1. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315 [TBL] [Abstract][Full Text] [Related]
2. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Aposhian MM; Dart RC; Woods JS; Ostrosky-Wegman P; Gonsebatt ME; Aposhian HV J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576 [TBL] [Abstract][Full Text] [Related]
3. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. Gonzalez-Ramirez D; Maiorino RM; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Aposhian MM; Dart RC; Diaz Gama JH; Echeverria D J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341 [TBL] [Abstract][Full Text] [Related]
4. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden. Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843 [TBL] [Abstract][Full Text] [Related]
5. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury. Zalups RK J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154 [TBL] [Abstract][Full Text] [Related]
6. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate. Cherian MG; Miles EF; Clarkson TW; Cox C J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303 [TBL] [Abstract][Full Text] [Related]
7. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554 [TBL] [Abstract][Full Text] [Related]
8. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Garza-Ocañas L; Torres-Alanís O; Piñeyro-López A J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436 [TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats. Juresa D; Blanusa M; Kostial K Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364 [TBL] [Abstract][Full Text] [Related]
11. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS). Aposhian HV Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487 [TBL] [Abstract][Full Text] [Related]
12. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. Maiorino RM; Dart RC; Carter DE; Aposhian HV J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628 [TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test. Torres-Alanís O; Garza-Ocañas L; Bernal MA; Piñeyro-López A J Toxicol Clin Toxicol; 2000; 38(7):697-700. PubMed ID: 11192456 [TBL] [Abstract][Full Text] [Related]
14. Increased inorganic mercury in spinal motor neurons following chelating agents. Ewan KB; Pamphlett R Neurotoxicology; 1996; 17(2):343-9. PubMed ID: 8856730 [TBL] [Abstract][Full Text] [Related]
16. [Biomonitoring for the evaluation of a mercury burden from amalgam fillings. Mercury determination in urine before and after oral doses of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and in hair]. Herrmann M; Schweinsberg F Zentralbl Hyg Umweltmed; 1993 May; 194(3):271-91. PubMed ID: 8338616 [TBL] [Abstract][Full Text] [Related]
17. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review. Muran PJ Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769 [TBL] [Abstract][Full Text] [Related]
18. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age. Kostial K; Kargacin B; Blanusa M; Landeka M Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703 [TBL] [Abstract][Full Text] [Related]
19. Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score. Aposhian HV; Bruce DC; Alter W; Dart RC; Hurlbut KM; Aposhian MM FASEB J; 1992 Apr; 6(7):2472-6. PubMed ID: 1563599 [TBL] [Abstract][Full Text] [Related]
20. Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: a study on subjects with dental amalgam. Høl PJ; Vamnes JS; Gjerdet NR; Eide R; Isrenn R Biol Trace Elem Res; 2003 Jan; 91(1):19-31. PubMed ID: 12713026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]